Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Rocuronium /kg

Phase 3Small molecule

MMedtronic - MITG

1

Indications

5

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[3][1]

Indication

Airway ManagementNot yet recruiting

Airway ManagementPhase 3

Not yet recruiting

Timeline

Expected Milestones

Q3 2027

ApprovedNot yet recruiting

Airway Management

NCT07828977

Clinical

Trials by Indication[1]

Neuromuscular Blockade3 trials

The Effect of Neuromuscular Blockade on the Composite Variability Index (CVI) During Laryngoscopy

Completed·MMedtronic - MITG·N/A·NCT01450813·80 enrolled

Influence of the Neuromuscular Blockade on Mask Ventilation

Completed·UUniversity of Rostock·N/A·NCT02318810·300 enrolled

Neuromuscular Blockade for Optimising Surgical Conditions During Spinal Surgery

Unknown status·TThe Catholic University of Korea·Phase 4·NCT02778945·60 enrolled

Elderly Patients1 trial

A Comparison of Rocuronium 0.6 mg/kg and Remifentanil 2 µg/kg in Elderly Patients Over 80 Years

Completed·RRigshospitalet, Denmark·Phase 4·NCT04287426·78 enrolled

Airway Management1 trial

The Relationship Between the Degree of Neuromuscular Blockade and the Conditions of Laryngeal Mask Ventilation: A Prospective Randomized Double-Blind Study

Not yet recruiting·KKorea University Guro Hospital·Approved·NCT07828977·96 enrolled

Sources

References

[1]
ClinicalTrials.gov — 5 trial records for Rocuronium /kg. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Rocuronium /kg compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Rocuronium /kg. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Medtronic - MITG company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: MMedtronic - MITG

Related News